Results 131 to 140 of about 16,712 (235)

Evaluating the Safety and Efficacy of Transcranial Pulse Stimulation on Autism Spectrum Disorder: A Double-Blinded, Randomized, Sham-Controlled Trial Protocol. [PDF]

open access: yesInt J Environ Res Public Health, 2022
Cheung T   +8 more
europepmc   +1 more source

Effects of online motor cortex transcranial ultrasound stimulation on interhemispheric inhibition

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend The present study investigated the online effect of primary motor cortex (M1) transcranial ultrasound stimulation (TUS) on interhemispheric inhibition (IHI) from the sonicated M1 to the contralateral M1 and on the contralateral M1 excitability.
Yanqiu Wang   +6 more
wiley   +1 more source

Transcranial direct current stimulation enhances delayed retention after 5 days of lower‐limb motor skill learning

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Schematic overview of the 5 day lower‐limb motor skill learning protocol combining ankle visuomotor practice with transcranial direct current stimulation (tDCS). Participants were allocated to motor skill practice with active tDCS over the leg representation of primary motor cortex (SKILL‐STIM), motor skill practice with sham ...
August Lomholt Kvistad   +5 more
wiley   +1 more source

Antidepressant effect of transcranial pulse stimulation (TPS) targeting neuropsychiatric disorders: a retrospective analysis. [PDF]

open access: yesPsychol Med
Mitterwallner M   +11 more
europepmc   +1 more source

Effects of Transcranial Pulse Stimulation (TPS) on Young Adults With Symptom of Depression: A Pilot Randomised Controlled Trial Protocol. [PDF]

open access: yesFront Neurol, 2022
Cheung T   +8 more
europepmc   +1 more source

Transcranial Magnetic Stimulation as a Translational Biomarker in Early‐Phase Anti‐Seizure Medication Development: A Randomized, Double‐Blind, Placebo‐Controlled Study in Generalized Epilepsy

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 3, Page 673-683, September 2026.
One‐third of epilepsy patients remain treatment‐resistant, underscoring the need for novel anti‐seizure medications (ASMs) and reliable biomarkers of central target engagement. Cortical hyperexcitability is a hallmark of epilepsy, making excitability a valuable pharmacodynamic biomarker for early‐phase drug development supporting go/no‐go decision ...
Catherine M. E. de Cuba   +7 more
wiley   +1 more source

Neuromodulation in Parkinson's disease with transcranial pulse stimulation: evidence of clinical efficacy and cortical oscillatory changes. [PDF]

open access: yesJ Neurol
Gianlorenco AC   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy